ZNF333
Zinc finger protein 333
Also known as: KIAA1806, ZN333_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96JL9
- Gene
- ZNF333
- Ensembl
- ENSG00000160961
- Chromosome
- 19
- Canonical length
- 665 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
665 residues, UniProt reviewed canonical sequence.
>Q96JL9|ZNF333
1 MESVTFEDVA VEFIQEWALL DSARRSLCKY RMLDQCRTLA SRGTPPCKPS CVSQLGQRAE
61 PKATERGILR ATGVAWESQL KPEELPSMQD LLEEASSRDM QMGPGLFLRM QLVPSIEERE
121 TPLTREDRPA LQEPPWSLGC TGLKAAMQIQ RVVIPVPTLG HRNPWVARDS AVPARDPAWL
181 QEDKVEEEAM APGLPTACSQ EPVTFADVAV VFTPEEWVFL DSTQRSLYRD VMLENYRNLA
241 SVADQLCKPN ALSYLEERGE QWTTDRGVLS DTCAEPQCQP QEAIPSQDTF TEILSIDVKG
301 EQPQPGEKLY KYNELEKPFN SIEPLFQYQR IHAGEASCEC QEIRNSFFQS AHLIVPEKIR
361 SGDKSYACNK CEKSFRYSSD LIRHEKTHTA EKCFDCQECG QAFKYSSNLR RHMRTHTGEK
421 PFECSQCGKT FTRNFNLILH QRNHTGEKPY ECKDCGKAFN QPSSLRSHVR THTGEKPFEC
481 SQCGKAFREH SSLKTHLRTH TREKPYECNQ CGKPFRTSTH LNVHKRIHTG EKLYECATCG
541 QVLSRLSTLK SHMRTHTGEK PYVCQECGRA FSEPSSLRKH ARTHSGKKPY ACQECGRAFG
601 QSSHLIVHVR THSAGRPYQC NQCEKAFRHS SSLTVHKRTH VGRETIRNGS LPLSMSHPYC
661 GPLANLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF333 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 7.6 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 7.6 nTPM
- ovary: 7.2 nTPM
- skeletal muscle: 7.2 nTPM
- blood vessel: 6.5 nTPM
- spleen: 6.5 nTPM
- endometrium: 6.3 nTPM
Single-cell type
- neutrophils: 55 nCPM
- microglia: 35 nCPM
- oligodendrocytes: 35 nCPM
- leydig cells: 33 nCPM
- fibro-adipogenic progenitors: 32 nCPM
- rod photoreceptor cells: 31 nCPM
Immune cell
- NK-cell: 14 nTPM
- basophil: 8.4 nTPM
- neutrophil: 6.3 nTPM
- eosinophil: 5.3 nTPM
- MAIT T-cell: 4.6 nTPM
- non-classical monocyte: 4.5 nTPM
Brain region
- white matter: 14 nTPM
- cerebellum: 13 nTPM
- pons: 11 nTPM
- basal ganglia: 11 nTPM
- cerebral cortex: 11 nTPM
- thalamus: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.82
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF333 as an antibody target. Whether an autoantibody or antibody against ZNF333 could matter depends on whether native ZNF333 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF333 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF333 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...